IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
+42.02%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$301M
AUM Growth
+$301M
(+37%)
Cap. Flow
+$25.5M
Cap. Flow
% of AUM
8.48%
Top 10 Holdings %
Top 10 Hldgs %
57.04%
Holding
59
New
3
Increased
11
Reduced
10
Closed
6
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$12.9M |
| 2 |
Exelixis
EXEL
|
$7.93M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$7.02M |
| 4 |
Gilead Sciences
GILD
|
$4.92M |
| 5 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$4.84M |
Top Sells
| 1 |
Merck
MRK
|
$6.4M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$3.71M |
| 3 |
Amgen
AMGN
|
$3.24M |
| 4 |
Eli Lilly
LLY
|
$2.77M |
| 5 |
Incyte
INCY
|
$2.2M |
Sector Composition
| 1 | Healthcare | 91.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Esperion Therapeutics
ESPR
$490M
| $452K | 0.15% |
9,500
| – | – |
|
52
AnaptysBio
ANAB
$630M
| $227K | 0.08% |
10,000
| – | – |
|
|
ZEAL
53
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
| $187K | 0.06% |
5,653
| – | – |
|
|
TCDA
54
DELISTED
Tricida, Inc. Common Stock
TCDA
| – | – |
-29,000
| Closed | -$635K |
|
55
Tempest Therapeutics
TPST
$46.6M
| – | – |
-177,825
| Closed | -$939K |
|
|
56
Merck
MRK
$210B
| – | – |
-83,200
| Closed | -$6.4M |
|
|
57
Eli Lilly
LLY
$661B
| – | – |
-20,000
| Closed | -$2.77M |
|
|
AMRN
58
Amarin Corp
AMRN
$311M
| – | – |
-320,000
| Closed | -$1.27M |
|
59
Alkermes
ALKS
$4.95B
| – | – |
-52,000
| Closed | -$749K |
|